Eurofins Scientific SE: Director/PDMR Shareholding

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities (“PDMR”). The notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the European Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Analytical Bioventures S.C.A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg
2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57
4.	Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		EUR 62.0751	2000
d)	Aggregated information
	— Aggregated volume	2000
	— Price	EUR 124,150.20
e)	Date of the transaction	2026-03-26
f)	Place of the transaction	XPAR

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Analytical Bioventures S.C.A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg
2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57
4.	Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		EUR 61.779	2000
d)	Aggregated information
	— Aggregated volume	2000
	— Price	EUR 123,558.00
e)	Date of the transaction	2026-03-27
f)	Place of the transaction	XPAR

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Analytical Bioventures S.C.A (RCS B89265) 23, Val Fleuri, L-1526 Luxembourg
2.	Reason for the notification
a)	Position / status	Analytical Bioventures S.C.A. is a company controlled by Eurofins Scientific S.E., CEO Dr. Gilles Martin
b)	Initial notification / amendment	Initial
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Eurofins Scientific S.E.
b)	LEI	529900JEHFM47DYY3S57
4.	Details of the transaction(s) section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Share
	Identification code	ISIN: FR0014000MR3
b)	Nature of the transaction	Acquisition of shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		EUR 61.8082	1867
d)	Aggregated information
	— Aggregated volume	1867
	— Price	EUR 115,395.91
e)	Date of the transaction	2026-03-30
f)	Place of the transaction	XPAR

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With over 65,000 staff across a network of more than 950 laboratories in over 1,000 companies in 59 countries, Eurofins offers a portfolio of over 200,000 analytical methods.

Eurofins Scientific S.E. shares are listed on Euronext Paris Stock Exchange.